Mitochondria-targeted therapies for Acute kidney injury

Expert Reviews in Molecular Medicine

Volumn 16, Issue , 2014, Pages

  Tábara, Luis Carlos ^a,b   Poveda, Jonay ^a,b   Martin Cleary, Catalina ^a,b   Selgas, Rafael ^b,c   Ortiz, Alberto ^a,b,d,e   Sanchez Niño, Maria D ^b,c,e  

^a UAM)   (Spain)

^b REDINREN   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e Instituto Reina Sofia de Investigacion Nefrol Ogica   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ARISTOLOCHIC ACID; CISPLATIN; CYCLOSPORIN A; ELAMIPRETIDE; GENTAMICIN; MDIVI 1; MITO CP; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOQUIDONE; QUINONE DERIVATIVE; SKQ1; SKQR1; SUPEROXIDE DISMUTASE; TENOFOVIR; UNCLASSIFIED DRUG; CARRIER PROTEIN; CYCLOSPORIN; MITOCHONDRIAL PROTEIN;

ACUTE KIDNEY FAILURE; ANTIOXIDANT ACTIVITY; CHEMICAL STRUCTURE; CLINICAL TRIAL (TOPIC); DRUG TARGETING; ENDOTOXEMIA; GENE EXPRESSION; HEART MUSCLE ISCHEMIA; HUMAN; KIDNEY TUBULE CELL; MEMBRANE STRUCTURE; MITOCHONDRIAL BIOGENESIS; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL GENE; MITOCHONDRION; MORPHOLOGY; MYOGLOBINURIA; NEPHROTOXICITY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION INJURY; REVIEW; ACUTE KIDNEY INJURY; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BIOSYNTHESIS; CELL DIVISION; DRUG EFFECTS; GENE EXPRESSION REGULATION; KIDNEY; METABOLISM; PATHOLOGY;

ACUTE KIDNEY INJURY; APOPTOSIS; CELL DIVISION; CYCLOSPORINE; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL PROTEINS; OXIDATIVE STRESS;

EID: 84925883323     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/erm.2014.14     Document Type: Review

References (149)

1. Moe, S. et al. (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney disease: improving global outcomes (KDIGO). Kidney International 69, 1945-1953
2. Bellomo, R., Kellum, J. A. and Ronco, C. (2012) Acute kidney injury. Lancet 380, 756-766
3. Perazella, M. A. and Coca, S. G. (2013) Three feasible strategies to minimize kidney injury in 'incipient AKI'. Nature Reviews Nephrology 9, 484-490
4. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney International Supplements 2, 1-138
5. Sanz, A. B. et al. (2008) Mechanisms of renal apoptosis in health and disease. Journal of the American Society of Nephrology 19, 1634-1642
6. Martinou, J. C. and Youle, R. J. (2011) Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Developmental Cell 21, 92-101
7. Vaux, D. L. (2011) Apoptogenic factors released from mitochondria. Biochimica et Biophysica Acta 1813, 546-550
8. ∗. Annual Review of Genetics 43, 95-118
9. Eaton, S., Bartlett, K. and Pourfarzam, M. (1996) Mammalian mitochondrial beta-oxidation. Biochemical Journal 320(Pt 2), 345-357
10. Chicco, A. J. and Sparagna, G. C. (2007) Role of cardiolipin alterations in mitochondrial dysfunction and disease. American Journal of Physiology Cell Physiology 292, C33-C44
11. Giorgio, V. et al. (2013) Dimers of mitochondrial ATP synthase form the permeability transition pore. Proceedings of the National Academy of Sciences of the United States of America 110, 5887-5892
12. Kokoszka, J. E. et al. (2004) The ADP/AT P translocator is not essential for the mitochondrial permeability transition pore. Nature 427, 461-465
13. Baines, C. P. et al. (2007) Voltage-dependent anion channels are dispensable for mitochondrialdependent cell death. Nature Cell Biology 9, 550-555
14. Anderson, S. et al. (1981) Sequence and organization of the human mitochondrial genome. Nature 290, 457-465
15. Pagliarini, D. J. et al. (2008) A mitochondrial protein compendium elucidates complex I disease biology. Cell 134, 112-123
16. Weinberg, J. M. (2011) Mitochondrial biogenesis in kidney disease. Journal of the American Society of Nephrology 22, 431-436
17. Wu, Z. et al. (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98, 115-124
18. Rasbach, K. A. and Schnellmann, R. G. (2007) Signaling of mitochondrial biogenesis following oxidant injury. Journal of Biological Chemistry 282, 2355-2362
19. Jin, S. M. and Youle, R. J. (2012) PINK1- and Parkinmediated mitophagy at a glance. Journal of Cell Science 125, 795-799
20. Liesa, M., Palacin, M. and Zorzano, A. (2009) Mitochondrial dynamics in mammalian health and disease. Physiology Review 89, 799-845
21. Bereiter-Hahn, J. and Voth, M. (1994) Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria. Microscopy Research and Technique 27, 198-219
22. Kageyama, Y., Zhang, Z. and Sesaki, H. (2011) Mitochondrial division: molecular machinery and physiological functions. Current Opinion in Cell Biology 23, 427-434
23. Labrousse, A. M. et al. (1999) C. elegans dynaminrelated protein DRP-1 controls severing of the mitochondrial outer membrane. Molecular Cell 4, 815-826
24. Smirnova, E. et al. (2001) Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Molecular Biology of the Cell 12, 2245-2256
25. Iglewski, M. et al. (2010) Mitochondrial fission and autophagy in the normal and diseased heart. Current Hypertension Reports 12, 418-425
26. Nunnari, J. and Suomalainen, A. (2012) Mitochondria: in sickness and in health. Cell 148, 1145-1159
27. Lanza, I. R. and Nair, K. S. (2010) Mitochondrial function as a determinant of life span. Pflugers Archiv: European Journal of Physiology 459, 277-289
28. Kowaltowski, A. J. and Vercesi, A. E. (1999) Mitochondrial damage induced by conditions of oxidative stress. Free Radical Biology and Medicine 26, 463-471
29. Thannickal, V. J. and Fanburg, B. L. (2000) Reactive oxygen species in cell signaling. American Journal of Physiology. Lung Cellular and Molecular Physiology 279, L1005-L1028
30. Pan, X. et al. (2013) The physiological role of mitochondrial calcium revealed bymice lacking the mitochondrial calcium uniporter. Nature Cell Biology 15, 1464-1472
31. Levi, S. and Rovida, E. (2009) The role of iron in mitochondrial function. Biochimica et Biophysica Acta 1790, 629-636
32. Tait, S. W. and Green, D. R. (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nature Review Molecular Cell Biology 11, 621-632
33. Chipuk, J. E. et al. (2010) The BCL-2 family reunion. Molecular Cell 37, 299-310
34. Linkermann, A. et al. (2013) Two independent pathways of regulated necrosis mediate ischemiareperfusion injury. Proceedings of the National Academy of Sciences of the United States of America 110, 12024-12029
35. Kinnally, K. W. et al. (2011) Is mPTP the gatekeeper for necrosis, apoptosis, or both? Biochimica et Biophysica Acta 1813, 616-622
36. De, G. F. et al. (2002) The permeability transition pore signals apoptosis by directing Bax translocation and multimerization. FASEB Journal 16, 607-609
37. Cardenas, C. et al. (2010) Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell 142, 270-283
38. Eng, C. H. et al. (2010) Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Science Signaling 3, ra31
39. Egan, D. F. et al. (2011) Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331, 456-461
40. Inoki, K., Zhu, T. and Guan, K. L. (2003) TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-590
41. Kim, J. et al. (2011) AMPK and mTOR regulate autophagy through directphosphorylation of Ulk1. Nature Cell Biology 13, 132-141
42. West, A. P., Shadel, G. S. and Ghosh, S. (2011) Mitochondria in innate immune responses. Nature Reviews Immunology 11, 389-402
43. Bulua, A. C. et al. (2011) Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). Journal of Experimental Medicine 208, 519-533
44. Vance, J. E. and Shiao, Y. J. (1996) Intracellular trafficking of phospholipids: import of phosphatidylserine into mitochondria. Anticancer Research 16, 1333-1339
45. Lebiedzinska, M. et al. (2009) Interactions between the endoplasmic reticulum, mitochondria, plasma membrane and other subcellular organelles. International Journal of Biochemistry and Cell Biology 41, 1805-1816
46. Sanchez-Nino, M. D. et al. (2012) Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy. American Journal of Physiology. Renal Physiology 302, F647-F657
47. Rojas-Rivera, J. et al. (2010) The expanding spectrum of biological actions of vitamin D. Nephrology Dialysis Transplantation 25, 2850-2865
48. Brooks, C. et al. (2009) Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. Journal of Clinical Investigation 119, 1275-1285
49. Szeto, H. H. et al. (2011) Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. Journal of the American Society of Nephrology 22, 1041-1052
50. Birk, A. V. et al. (2013) The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. Journal of the American Society of Nephrology 24, 1250-1261
51. Eirin, A. et al. (2012) A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis. Hypertension 60, 1242-1249
52. Parajuli, N. et al. (2012) MitoQ blunts mitochondrial and renal damage during cold preservation of porcine kidneys. PLoS ONE 7, e48590
53. Mukhopadhyay, P. et al. (2012) Mitochondrialtargeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy. Free Radical Biology and Medicine 52, 497-506
54. Jankauskas, S. S. et al. (2012) Mitochondria-targeted antioxidant SkQR1 ameliorates gentamycininduced renal failure and hearing loss. Biochemistry (Mosc.) 77, 666-670
55. Funk, J. A. and Schnellmann, R. G. (2012) Persistent disruption of mitochondrial homeostasis after acute kidney injury. American Journal of Physiology. Renal Physiology 302, F853-F864
56. Tang, W. X. et al. (2013) Amelioration of rhabdomyolysis-induced renal mitochondrial injury and apoptosis through suppression of Drp-1 translocation. Journal of Nephrology 26, 1073-1082
57. Plotnikov, E. Y. et al. (2011) Mechanisms of nephroprotective effect of mitochondria-targeted antioxidants under rhabdomyolysis and ischemia/reperfusion. Biochimica et Biophysica Acta 1812, 77-86
58. Jiang, Z. et al. (2013) Possible role of mtDNA depletion and respiratory chain defects in aristolochic acid I-induced acute nephrotoxicity. Toxicology and Applied Pharmacology 266, 198-203
59. Herlitz, L. C. et al. (2010) Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities. Kidney International 78, 1171-1177
60. Tanji, N. et al. (2001) Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. Human Pathology 32, 734-740
61. Kohler, J. J. et al. (2009) Tenofovir renal toxicity targets mitochondria of renal proximal tubules. Laboratory Investigation 89, 513-519
62. Tran, M. et al. (2011) PGC-1alpha promotes recovery after acute kidney injury during systemic inflammation in mice. Journal of Clinical Investigation 121, 4003-4014
63. Hall, A. M.etal. (2013) Invivo multiphotonimaging of mitochondrial structure and function during acute kidney injury. Kidney International 83, 72-83
64. Porta, F. et al. (2006) Effects of prolonged endotoxemia on liver, skeletal muscle and kidney mitochondrial function. Critical Care 10, R118
65. Abraham, P., Ramamoorthy, H. and Isaac, B. (2013) Depletion of the cellular antioxidant system contributes to tenofovir disoproxil fumarate - induced mitochondrial damage and increased oxido-nitrosative stress in the kidney. Journal of Biomedical Science 20, 61
66. Plotnikov, E. Y. et al. (2009) Myoglobin causes oxidative stress, increase of NO production and dysfunction of kidney's mitochondria. Biochimica et Biophysica Acta 1792, 796-803
67. Liu, X. and Hajnoczky, G. (2011) Altered fusion dynamics underlie unique morphological changes in mitochondria during hypoxiareoxygenation stress. Cell Death and Differentiation 18, 1561-1572
68. Zsengeller, Z. K. et al. (2012) Cisplatin nephrotoxicity involves mitochondrial injury with impaired tubular mitochondrial enzyme activity. Journal of Histochemistry and Cytochemistry 60, 521-529
69. Fernandez-Fernandez, B. et al. (2011) Tenofovir nephrotoxicity: 2011 update. AIDS Research and Treatment 2011, 354908
70. Plotnikov, E. Y. et al. (2007) The roleofmitochondria in oxidative and nitrosative stress during ischemia/reperfusion in the rat kidney. Kidney International 72, 1493-1502
71. Burke, T. J. et al. (1983) Role of mitochondria in ischemic acute renal failure. Clinical and Experimental Dialysis and Apheresis 7, 49-61
72. Sun, Z. et al. (2008) Amelioration of oxidative mitochondrial DNA damage and deletion after renal ischemic injury by the KATP channel opener diazoxide. American Journal of Physiology. Renal Physiology 294, F491-F498
73. Weinberg, J. M. et al. (2000) Mitochondrial dysfunction during hypoxia/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediates. Proceedings of the National Academy of Sciences of the United States of America 97, 2826-2831
74. Devarajan, P. (2006) Update on mechanisms of ischemic acute kidney injury. Journal of the American Society of Nephrology 17, 1503-1520
75. Pfaller, W., Gstraunthaler, G. and Willinger, C. C. (1990) Morphology of renal tubular damage from nephrotoxins. Toxicology Letters 53, 39-43
76. Izzedine, H. et al. (2003) Drug-induced Fanconi's syndrome. American Journal of Kidney Disease 41, 292-309
77. Feldkamp, T., Kribben, A. and Weinberg, J. M. (2005) Assessment of mitochondrial membrane potential in proximal tubules after hypoxiareoxygenation. American Journal of Physiology. Renal Physiology 288, F1092-F1102
78. Hall, A. M. and Unwin, R. J. (2007) The not so 'mighty chondrion': emergence of renal diseases due to mitochondrial dysfunction. Nephron Physiology 105, 1-10
79. Jassem, W. et al. (2002) The role of mitochondria in ischemia/reperfusion injury. Transplantation 73, 493-499
80. Jassem, W. and Heaton, N. D. (2004) The role of mitochondria in ischemia/reperfusion injury in organ transplantation. Kidney International 66, 514-517
81. Nath, K. A. et al. (1998) Intracellular targets in heme protein-induced renal injury. Kidney International 53, 100-111
82. Beiral, H. J. et al. (2012) The impact of stem cells on electron fluxes, proton translocation and ATP synthesis in kidney mitochondria after Ischemia/Reperfusion. Cell Transplantation 23, 207-220
83. Shah, S. V. and Walker, P. D. (1988) Evidence suggesting a role for hydroxyl radical in glycerolinduced acute renal failure. American Journal of Physiology 255, F438-F443
84. Zager, R. A. (1996) Mitochondrial free radical production induces lipid peroxidation during myohemoglobinuria. Kidney International 49, 741-751
85. Crompton, M. (1999) The mitochondrial permeability transition pore and its role in cell death. Biochemical Journal 341(Pt 2), 233-249
86. Bonventre, J. V. (1993) Mechanisms of ischemic acute renal failure. Kidney International 43, 1160-1178
87. Bonventre, J. V. and Weinberg, J. M. (2003) Recent advances in the pathophysiology of ischemic acute renal failure. Journal of the American Society of Nephrology 14, 2199-2210
88. Bosch, X., Poch, E. and Grau, J. M. (2009) Rhabdomyolysis and acute kidney injury. The New England Journal of Medicine 361, 62-72
89. Wang, W. et al. (2008) Superoxide flashes in single mitochondria. Cell 134, 279-290
90. Korge, P., Ping, P. and Weiss, J. N. (2008) Reactive oxygen species production in energized cardiac mitochondria during hypoxia/reoxygenation: modulation by nitric oxide. Circulation Research 103, 873-880
91. Weinberg, J. M. et al. (1997) Glycine-protected, hypoxic, proximal tubules develop severely compromised energetic function. Kidney International 52, 140-151
92. Heyman, S. N. et al. (2012) Cellular adaptive changes in AKI: mitigating renal hypoxic injury. Nephrology Dialysis Transplantation 27, 1721-1728
93. Brooks, C. et al. (2011) Fragmented mitochondria aresensitizedtoBax insertion and activation during apoptosis. American Journal of Physiology. Cell Physiology 300, C447-C455
94. Gall, J. M. et al. (2012) Roleofmitofusin2inthe renal stress response. PLoS ONE 7, e31074
95. Justo, P. et al. (2003) Expression of Smac/Diablo in tubular epithelial cells and during acute renal failure. Kidney International Supplement S52-S56
96. Lorz, C. et al. (2005) Role of Bcl-xL in paracetamolinduced tubular epithelial cell death. Kidney International 67, 592-601
97. Mortensen, J. et al. (2011) MnTMPyP, a superoxide dismutase/catalase mimetic, decreases inflammatory indices in ischemic acute kidney injury. Inflammation Research 60, 299-307
98. Devalaraja-Narashimha, K., Diener, A. M. and Padanilam, B. J. (2009) Cyclophilin D gene ablation protects mice from ischemic renal injury. American Journal of Physiology. Renal Physiology 297, F749-F759
99. Gottlieb, R. A. (2011) Cell death pathways in acute ischemia/reperfusion injury. Journal of Cardiovascular Pharmacology Therapy 16, 233-238
100. Shi, J. et al. (2013) PGC1alpha plays a critical role in TWEAK-induced cardiac dysfunction. PLoS ONE 8, e54054
101. Zhang, H. et al. (2007) HIF-1 inhibits mitochondrial biogenesis and cellularrespiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 11, 407-420
102. Wegrzyn, J. et al. (2009) Function of mitochondrial Stat3 in cellular respiration. Science 323, 793-797
103. Sanz, A. B., Sanchez-Nino, M. D. and Ortiz, A. (2011) TWEAK, a multifunctional cytokine in kidney injury. Kidney International 80, 708-718
104. Sanz, A. B. et al. (2010) TWEAK activates the noncanonical NFkappaB pathway in murine renal tubular cells: modulation of CCL21. PLoS ONE 5, e8955
105. Ucero, A. C. et al. (2013) TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast, Biochimica et Biophysica Acta 1832, 1744-1755
106. Papandreou, I. et al. (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metabolism 3, 187-197
107. Fernandez-Sanchez, R. et al. (2012) AG490 promotes HIF-1alpha accumulation by inhibiting its hydroxylation. Current Medical Chemistry 19, 4014-4023
108. Goncalves, S. et al. (2010) Tyrphostins as potential therapeutic agents for acute kidney injury. Current Medical Chemistry 17, 974-986
109. Neria, F. et al. (2009) Inhibition of JAK2 protects renal endothelial and epithelial cells from oxidative stress and cyclosporin A toxicity. Kidney International 75, 227-234
110. Ortiz, A. et al. (2003) Targeting apoptosis in acute tubular injury. Biochemical Pharmacology 66, 1589-1594
111. Wei, Q. et al. (2013) Baxand Bak have critical roles in ischemic acute kidney injuryinglobal and proximal tubule-specific knockout mouse models. Kidney International 84, 138-148
112. Sheridan, C. et al. (2008) Bax- or Bak-induced mitochondrial fission can be uncoupled from cytochrome C release. Molecular Cell 31, 570-585
113. Wen, X. et al. (2012) One dose of cyclosporine A is protective at initiation of folic acid-induced acute kidney injury in mice. Nephrology Dialysis Transplantation 27, 3100-3109
114. Bakeeva, L. E. et al. (2008) Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke). Biochemistry (Mosc.) 73, 1288-1299
115. Piot, C. et al. (2008) Effect of cyclosporine on reperfusion injury in acute myocardial infarction. The New England Journal of Medicine 359, 473-481
116. Mott, J. L. et al. (2004) Cardiac disease due to random mitochondrial DNA mutations is prevented by cyclosporin A. Biochemical and Biophysical Research Communications 319, 1210-1215
117. Elrod, J. W. et al. (2010) Cyclophilin D controls mitochondrial pore-dependent Ca (2+) exchange, metabolic flexibility, and propensity for heart failure in mice. Journal of Clinical Investigation 120, 3680-3687
118. Cho, S. G. et al. (2010) Drp1 dephosphorylation in ATP depletion-induced mitochondrial injury and tubular cell apoptosis. American Journal of Physiology. Renal Physiology 299, F199-F206
119. Cereghetti, G. M. et al. (2008) Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proceedings of the National Academy of Sciences of the United States of America 105, 15803-15808
120. Gonzalez-Guerrero, C. et al. (2013) Calcineurin inhibitors recruit protein kinases JAK2 and JNK, TLR signaling and the UPR to activate NF-kappaB-mediated inflammatory responses in kidney tubular cells. Toxicology and Applied Pharmacology 272, 825-841
121. Berzal, S. et al. (2012) GSK3, snail, and adhesion molecule regulation by cyclosporine A in renal tubular cells. Toxicology Science 127, 425-437
122. de, A. G. et al. (2013) Cyclosporine A-induced apoptosis in renal tubular cells is related to oxidative damage and mitochondrial fission. Toxicology Letters 218, 30-38
123. Puigmule, M. et al. (2009) Differential proteomic analysis of cyclosporine A-induced toxicity in renal proximal tubule cells. Nephrology Dialysis Transplantation 24, 2672-2686
124. Baines, C. P. et al. (2005) Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658-662
125. Nakagawa, T. et al. (2005) Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434, 652-658
126. Quarato, G. et al. (2012) The cyclophilin inhibitor alisporivir prevents hepatitis C virus-mediated mitochondrial dysfunction. Hepatology 55, 1333-1343
127. Ong, S. B. and Hausenloy, D. J. (2010) Mitochondrial morphology and cardiovascular disease. Cardiovascular Research 88, 16-29
128. Arnoult, D. et al. (2005) Release of OPA1 during apoptosis participates in the rapid and complete release of cytochrome c and subsequent mitochondrial fragmentation. Journal of Biological Chemistry 280, 35742-35750
129. Frezza, C. et al. (2006) OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126, 177-189
130. Zhan, M. et al. (2013) Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology. Kidney International 83, 568-581
131. Cassidy-Stone, A. et al. (2008) Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Developmental Cell 14, 193-204
132. Ong, S. B. et al. (2010) Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 121, 2012-2022
133. Hall, A. M. (2013) Maintaining mitochondrial morphology in AKI: looks matter. Journal of the American Society of Nephrology 24, 1185-1187
134. Tepel, M. et al. (2000) Prevention of radiographiccontrast-agent-induced reductionsinrenalfunction by acetylcysteine. The New England Journal of Medicine 343, 180-184
135. Marenzi, G. et al. (2006) N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. The New England Journal of Medicine 354, 2773-2782
136. Fishbane, S. (2008) N-acetylcysteine in the prevention of contrast-induced nephropathy. Clinical Journal of the American Society of Nephrology 3, 281-287
137. Brueck, M. et al. (2013) Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial. Journal of Invasive Cardiology 25, 276-283
138. Tasanarong, A. et al. (2013) New strategy of alphaand gamma-tocopherol to prevent contrastinduced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures. Nephrology Dialysis Transplantation 28, 337-344
139. Chakrabarti, A. K. et al. (2013) Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction. American Heart Journal 165, 509-514
140. Kloner, R. A. et al. (2012) Reduction of ischemia/reperfusion injury with bendavia, a mitochondriatargeting cytoprotective peptide. Journal of American Heart Association 1, e001644
141. Kelso, G. F. et al. (2001) Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. Journal of Biological Chemistry 276, 4588-4596
142. Smith, R. A. and Murphy, M. P. (2010) Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Annals of the New York Academy of Sciences 1201, 96-103
143. Mitchell, T. et al. (2011) The mitochondria-targeted antioxidant mitoquinone protects against cold storage injuryof renal tubular cells and rat kidneys. Journal of Pharmacology Experimental Therapy 336, 682-692
144. Antonenko, Y. N. et al. (2008) Mitochondriatargeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: synthesis and in vitro studies. Biochemistry (Mosc.) 73, 1273-1287
145. Skulachev, M. V. et al. (2011) Mitochondrialtargeted plastoquinone derivatives. Effect on senescence and acute age-related pathologies. Current Drug Targets. 12, 800-826
146. Stefanova, N. A. et al. (2013) Alzheimer's diseaselike pathology in senescence-accelerated OXYS rats can be partially retarded with mitochondriatargeted antioxidant SkQ1. Journal of Alzheimers Disease 38, 681-694
147. Plotnikov, E. Y. et al. (2012) Mild uncoupling of respiration and phosphorylation as a mechanism providing nephro- and neuroprotective effects of penetrating cations of the SkQ family. Biochemistry (Mosc.) 77, 1029-1037
148. Dilip, A. et al. (2013) Mitochondria-targeted antioxidant and glycolysis inhibition: synergistic therapy in hepatocellular carcinoma. Anticancer Drugs 24, 881-888
149. Sharma, K. et al. (2013) Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. Journal of the American Society of Nephrology 24, 1901-1912